Skip to content

Drug interactions

Palbociclib + Trastuzumab deruxtecan

Severity: Moderate

Palbociclib and Trastuzumab deruxtecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can cause neutropenia and interstitial lung disease. Combined use may increase the risk of febrile neutropenia and infection.

What this interaction means in plain words

Palbociclib and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Palbociclib belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.

Evidence level: Low

Why it happens

Additive myelosuppression; no pharmacokinetic interaction is established.

What to do

Monitor complete blood counts before each cycle and watch for fever or infection. Hold or reduce doses according to labeling for neutropenia, and monitor for respiratory symptoms.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Palbociclib and Trastuzumab deruxtecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Palbociclib with Trastuzumab deruxtecan?

MediHelp rates the interaction as moderate. Palbociclib and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can cause neutropenia and interstitial lung disease. Combined use may increase the risk of febrile neutropenia and infection.

How serious is the interaction between Palbociclib and Trastuzumab deruxtecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts before each cycle and watch for fever or infection. Hold or reduce doses according to labeling for neutropenia, and monitor for respiratory symptoms.

What other medicines interact with Palbociclib?

MediHelp also lists interactions of Palbociclib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Palbociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in